Medicare Enrolled

Dr. Lyudmila Schultz, ARNP

Nurse Practitioner - Adult Health · Lagrange, GA
Low-engagement
1075 LAFAYETTE PKWY STE 100, Lagrange, GA 30241
7064435273
In practice since 2015 (10 years)
NPI: 1376910547 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schultz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schultz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schultz

Dr. Lyudmila Schultz is a nurse practitioner - adult health in Lagrange, GA, with 10 years of NPI registration.

Between the years covered by Open Payments, Dr. Schultz received a total of $4,759 from 48 pharmaceutical and/or device companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schultz is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice $4,759 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,759
Total received (2021-2024)
Avg $1,190/year across 4 years
Top 8% in GA for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
210
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,559 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$199 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,806
2023
$1,703
2022
$999
2021
$251

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$211
Novartis Pharmaceuticals Corporation
$188
Bayer Healthcare Pharmaceuticals Inc.
$122
Daiichi Sankyo Inc.
$120
Janssen Biotech, Inc.
$102
Regeneron Healthcare Solutions, Inc.
$97
AstraZeneca Pharmaceuticals LP
$94
PFIZER INC.
$94
E.R. Squibb & Sons, L.L.C.
$85
Incyte Corporation
$72
Gilead Sciences, Inc.
$67
GENZYME CORPORATION
$53
Dendreon Pharmaceuticals LLC
$52
Takeda Pharmaceuticals U.S.A., Inc.
$48
Pharmacosmos Therapeutics Inc.
$39
EMD Serono, Inc.
$35
Genentech USA, Inc.
$34
ABBVIE INC.
$30
ADC Therapeutics America, Inc.
$28
GlaxoSmithKline, LLC.
$26
PUMA BIOTECHNOLOGY, INC.
$24
TAIHO ONCOLOGY, INC.
$21
Deciphera Pharmaceuticals Inc.
$21
Lilly USA, LLC
$21
Aveo Pharmaceuticals, Inc.
$20
Karyopharm Therapeutics Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
JAZZ PHARMACEUTICALS INC.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Astellas Pharma US Inc
$16
CSL Behring
$13
Top 3 companies account for 28.9% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$474
Merck Sharp & Dohme LLC
$408
GENZYME CORPORATION
$285
Incyte Corporation
$277
Bayer Healthcare Pharmaceuticals Inc.
$263
Daiichi Sankyo Inc.
$240
Janssen Biotech, Inc.
$193
Seagen Inc.
$181
PFIZER INC.
$175
Regeneron Healthcare Solutions, Inc.
$168
Gilead Sciences, Inc.
$165
AstraZeneca Pharmaceuticals LP
$162
Takeda Pharmaceuticals U.S.A., Inc.
$142
Celgene Corporation
$142
E.R. Squibb & Sons, L.L.C.
$138
Astellas Pharma US Inc
$119
Kite Pharma, Inc.
$100
Lilly USA, LLC
$90
ARRAY BIOPHARMA INC
$78
EISAI INC.
$65
EMD Serono, Inc.
$65
Genentech USA, Inc.
$59
Dendreon Pharmaceuticals LLC
$52
Karyopharm Therapeutics Inc.
$52
Pharmacyclics LLC, An AbbVie Company
$52
CTI BioPharma Corp.
$46
Eisai Inc.
$45
PUMA BIOTECHNOLOGY, INC.
$44
Pharmacosmos Therapeutics Inc.
$39
Deciphera Pharmaceuticals Inc.
$36
Puma Biotechnology, Inc.
$35
JAZZ PHARMACEUTICALS INC.
$34
ABBVIE INC.
$30
Bayer HealthCare Pharmaceuticals Inc.
$30
ADC Therapeutics America, Inc.
$28
GlaxoSmithKline, LLC.
$26
Epizyme, Inc.,
$22
TAIHO ONCOLOGY, INC.
$21
Ipsen Biopharmaceuticals, Inc
$20
Adaptive Biotechnologies Corporation
$20
Aveo Pharmaceuticals, Inc.
$20
Blueprint Medicines Corporation
$19
Rigel Pharmaceuticals, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
AMAG Pharmaceuticals, Inc.
$14
CSL Behring
$13
Top 3 companies account for 24.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · BAVENCIO · BOSULIF · BRAFTOVI · CABLIVI · CALQUENCE · CARVYKTI · COSELA · Columvi · DARZALEX · ELREXFIO · ENHERTU · ERLEADA · EXKIVITY · Enhertu · FERAHEME · FOTIVDA · Fabhalta · Hizentra · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · Lenvima · MEKINIST · MONJUVI · NERLYNX · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · QINLOCK · RYBREVANT · SARCLISA · Stivarga · TABRECTA · TAZVERIK · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VERZENIO · Venclexta · Vonjo · XALKORI · XPOVIO · XTANDI · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for nurse practitioner - adult health in GA.

Looking for a nurse practitioner - adult health in Lagrange?
Compare adult-health nurse practitioners in the Lagrange area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners within 10 mi
6
Per 100K population
8.6
County median income
$54,905
Nearest hospital
WELLSTAR WEST GEORGIA MEDICAL CENTER
9.5 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schultz is a nurse practitioner - adult health, with low-engagement industry engagement in the top 8% of GA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Schultz receive payments from pharmaceutical companies?
Yes. Dr. Schultz received a total of $4,759 from 48 companies across 210 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Schultz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Adult-Health Nurse Practitioners in Lagrange
Browse adult-health nurse practitioners in Lagrange ranked by procedure volume and transparency data.
Highest volume
Top Adult-Health Nurse Practitioners in GA
Adult-health nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult-Health Nurse Practitioners in GA
Which GA adult-health nurse practitioners receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →